Skip to main content
. 2009 Aug 31;53(11):4840–4844. doi: 10.1128/AAC.00462-09

TABLE 1.

Summary of the steady-state pharmacokinetics for TPV and RTVa

PK parameter TPV/r TPV/r + EFV GMR (90% CI)
TPV
    AUC (h·μM) 858.9 (28.9) 834.2 (39.2) 0.97 (0.87-1.09)
    Cmax (μM) 128.7 (22.0) 118.0 (34.0) 0.92 (0.81-1.03)
    Cmin (μM) 27.9 (57.1) 33.3 (63.1) 1.19 (0.93-1.54)
    Tmax (h) 2.0 (1.5-2.0) 3.0 (1.5-4.0)
    t1/2 (h) 4.0 (32.1) 4.7 (32.4)
    Vz/F (liter) 5.54 (31.4) 6.72 (50.7)
    CL/F (liter/h) 0.97 (28.9) 0.99 (39.2)
RTV
    AUC (h·μg/ml) 6.48 (50.8) 6.70 (71.4) 1.03 (0.78-1.38)
    Cmax (μg/ml) 1.52 (65.6) 1.40 (89.1) 0.92 (0.65-1.30)
    Cmin (μg/ml) 0.112 (101.5) 0.116 (87.0) 1.04 (0.72-1.48)
    Tmax (h) 4.0 (1-10.1) 4.0 (1.5-12.0)
    t1/2 (h)b 1.8 (23.6) 2.0 (55.7)
    Vz/F (liter)b 76.7 (54.2) 78.3 (137.9)
    CL/F (L/h) 30.9 (50.8) 29.9 (71.4)
a

Values are geometric means, with the geometric CV (%) given parenthetically, except for the Tmax value, which is a median, with the minimum to maximum values given parenthetically.

b

n = 15; for all others, n = 16.